Champions Oncology Inc. | Ownership
Companies that own Champions Oncology Inc.
Perceptive Advisors LLC
366,972
3.35%
-1
0.07%
06/30/2018
The Vanguard Group, Inc.
152,722
1.39%
0
0%
06/30/2018
Granite Investment Partners LLC
139,698
1.27%
0
0.07%
06/30/2018
Tocqueville Asset Management LP
114,951
1.05%
114,951
0.01%
06/30/2018
Perkins Capital Management, Inc.
103,000
0.94%
103,000
0.55%
06/30/2018
Essex Investment Management Co. LLC
101,962
0.93%
101,962
0.11%
06/30/2018
Renaissance Technologies LLC
100,600
0.92%
39,000
0%
06/30/2018
DWS Investment GmbH
17,100
0.16%
17,100
0%
06/30/2018
BlackRock Fund Advisors
15,281
0.14%
15,281
0%
06/30/2018
Commonwealth Equity Services, Inc.
11,910
0.11%
11,910
0%
06/30/2018
| Address |
One University Plaza
Hackensack New Jersey 07601
United States
|
|
Employees
|
- |
| Website |
http://www.championsoncology.com |
| Updated |
07/08/2019 |
| Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. |
